5331 private links
Carl Higbie
@CarlHigbie
Before the cameras arrived vs after… COVID theater. This is why we don’t trust these people
Clay Travis
@ClayTravis
·
Sep 10, 2021
Dr. Fauci was finally asked why people with natural immunity should be required to get the covid vaccine given studies that show we have more protection.
His response: “I don’t have a really firm answer for you on that.” //
So let me get this straight. The head of NIAID and the face of the pandemic response has no idea whether natural immunity exists or is durable? He’s seen none of the studies that show natural immunity confers stronger protection than two doses of the vaccine? He hasn’t looked at any of the real-world data sets? He hasn’t seen any of the numbers from the United Kingdom or Israel? Really? //
We are led by dishonest hacks who are putting politics above the health of Americans. That is why there’s vaccine hesitancy, not because of Fox News or Donald Trump. No one trusts these people because they do not deserve any trust. They continually mislead and make decisions based on what fits the narrative they want and not based on where the facts lead.
Northeastern Health System
NE Oklahoma Heart Center
Cherokee Health Partners
Pafford EMS
CONTACT
213 East Redwood Ave.
Sallisaw, OK 74955
Message from the administration of Northeastern Health System - Sequoyah:
Although Dr. Jason McElyea is not an employee of NHS Sequoyah, he is affiliated with a medical staffing group that provides coverage for our emergency room.
With that said, Dr. McElyea has not worked at our Sallisaw location in over 2 months.
NHS Sequoyah has not treated any patients due to complications related to taking ivermectin. This includes not treating any patients for ivermectin overdose.
All patients who have visited our emergency room have received medical attention as appropriate. Our hospital has not had to turn away any patients seeking emergency care.
We want to reassure our community that our staff is working hard to provide quality healthcare to all patients. We appreciate the opportunity to clarify this issue and as always, we value our community’s support.
COVID has revealed a lot over the last year and a half, but no country has been exposed more for its underlying culture of tyranny than Australia. Formerly a beacon of freedom, community, and beautiful landscapes, the land down under has morphed into a dystopian hellscape where the government blesses its residents with an hour of free time a day. The former prison colony has reverted to its roots.
Nowhere is that more apparent than in the COVID internment camps now operating in Australia. Travelers, both foreign and domestic are forced into one of the various metal buildings to serve out their 14-day sentence. There, they remain “quarantined,” only to be delivered food by faceless operatives in full protective gear.
This per The New York Times.
https://www.nytimes.com/2021/08/20/world/australia/howard-springs-quarantine.html
Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial
Background Ivermectin, an anti-parasitic agent, also has anti-viral properties. Our aim was to assess whether ivermectin can shorten the viral shedding in patients at an early-stage of COVID-19 infection.
Methods The double-blinded trial compared patients receiving ivermectin 0·2 mg/kg for 3 days vs. placebo in non-hospitalized COVID-19 patients. RT-PCR from a nasopharyngeal swab was obtained at recruitment and then every two days. Primary endpoint was reduction of viral-load on the 6th day (third day after termination of treatment) as reflected by Ct level>30 (non-infectious level). The primary outcome was supported by determination of viral culture viability.
Results Eighty-nine patients were eligible (47 in ivermectin and 42 in placebo arm). Their median age was 35 years. Females accounted for 21·6%, and 16·8% were asymptomatic at recruitment. Median time from symptom onset was 4 days. There were no statistical differences in these parameters between the two groups.
On day 6, 34 out of 47 (72%) patients in the ivermectin arm reached the endpoint, compared to 21/ 42 (50%) in the placebo arm (OR 2·62; 95% CI: 1·09-6·31). In a multivariable logistic-regression model, the odds of a negative test at day 6 was 2.62 time higher in the ivermectin group (95% CI: 1·06–6·45). Cultures at days 2 to 6 were positive in 3/23 (13·0%) of ivermectin samples vs. 14/29 (48·2%) in the placebo group (p=0·008).
Conclusions There were significantly lower viral loads and viable cultures in the ivermectin group, which could lead to shortening isolation time in these patients.
The study is registered at ClinicalTrials.gov NCT 044297411.
Double-blind study shows ivermectin reduces disease’s duration and infectiousness • FDA and WHO caution against its use //
Ivermectin, a drug used to fight parasites in third-world countries, could help reduce the length of infection for people who contract coronavirus for less than a $1 a day, according to recent research by Sheba Medical Center in Tel Hashomer.
Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba, conducted a randomized, controlled, double-blinded trial from May 15, 2020, through the end of January 2021 to evaluate the effectiveness of ivermectin in reducing viral shedding among nonhospitalized patients with mild to moderate COVID-19.
Ivermectin has been approved by the US Food and Drug Administration since 1987. The drug’s discoverers were awarded the 2015 Nobel Prize in medicine for its treatment of onchocerciasis, a disease caused by infection with a parasitic roundworm.
Over the years, it has been used for other indications, including scabies and head lice. Moreover, in the last decade, several clinical studies have started to show its antiviral activity against viruses ranging from HIV and the flu to Zika and West Nile. //
In Schwartz’s study, some 89 eligible volunteers over the age of 18 who were diagnosed with coronavirus and staying in state-run COVID-19 hotels were divided into two groups: 50% received ivermectin, and 50% received a placebo, according to their weight. They were given the pills for three days in a row, an hour before a meal.
The volunteers were tested using a standard nasopharyngeal swab PCR test with the goal of evaluating whether there was a reduction in viral load by the sixth day – the third day after termination of the treatment. They were swabbed every two days.
Nearly 72% of volunteers treated with ivermectin tested negative for the virus by day six. In contrast, only 50% of those who received the placebo tested negative.
IN ADDITION, the study looked at culture viability, meaning how infectious the patients were, and found that only 13% of ivermectin patients were infectious after six days, compared with 50% of the placebo group – almost four times as many.
“Our study shows first and foremost that ivermectin has antiviral activity,” Schwartz said. “It also shows that there is almost a 100% chance that a person will be noninfectious in four to six days, which could lead to shortening isolation time for these people. This could have a huge economic and social impact.”
The study appeared on the MedRxiv health-research sharing site. It has not yet been peer reviewed.
https://www.medrxiv.org/content/10.1101/2021.05.31.21258081v1
Schwartz said other similar studies – though not all of them conducted to the same double-blind and placebo standards as his – also showed a favorable impact of ivermectin treatment.
His study did not prove ivermectin was effective as a prophylactic, meaning that it could prevent disease, he cautioned, nor did it show that it reduces the chances of hospitalization. However, other studies have shown such evidence, he added.
For example, the study published earlier this year in the American Journal of Therapeutics highlighted that “a review by the Front Line COVID-19 Critical Care Alliance summarized findings from 27 studies on the effects of ivermectin for the prevention and treatment of COVID-19 infection, concluding that ivermectin ‘demonstrates a strong signal of therapeutic efficacy’ against COVID-19.”
Schwartz said he became interested in exploring ivermectin about a year ago, “when everyone was looking for a new drug” to treat COVID-19, and a lot of effort was being put into evaluating hydroxychloroquine, so he decided to join the effort.
“Since ivermectin was on my shelf, since we are using it for tropical diseases, and there were hints it might work, I decided to go for it,” he said.
Researchers in other places worldwide began looking into the drug at around the same time. But when they started to see positive results, no one wanted to publish them, Schwartz said.
“There is a lot of opposition,” he said. “We tried to publish it, and it was kicked away by three journals. No one even wanted to hear about it. You have to ask how come when the world is suffering.”
“This drug will not bring any big economic profits,” and so Big Pharma doesn’t want to deal with it, he said. //
“You would think Merck would be happy to hear that ivermectin might be helpful to corona patients and try to study it, but they are most loudly declaring the drug should not be used,” Schwartz said. “A billion people took it. They gave it to them. It’s a real shame.”
Liberal Talking Point About Joe Rogan and Ivermectin Gets Blown up From Unexpected Source – RedState
the discussion of ivermectin infuriated some folks on the left. They were beside themselves that Rogan mentioned it, attacking it as a “horse dewormer.” //
Because ivermectin isn’t just a “horse dewormer.” While it’s not approved by the FDA for use for COVID, it’s an anti-parasitic drug, approved for humans for other purposes.
Indeed the guy who came up with it, William Campbell, won the Nobel Prize for it in 2015, because of its significant contribution toward helping combat parasites that caused problems for about 100 million people around the world. “Treatment is so successful that these diseases are on the verge of eradication, which would be a major feat in the medical history of humankind,” the Nobel committee said.
So anyone calling it a horse dewormer is revealing they don’t understand how it’s been used. And one thing that’s really hilarious, given this “fake news” about it just being a “horse dewormer” is who is recommending the usage of ivermectin for refugees coming into the country to fight issues of parasites: the CDC.
https://www.cdc.gov/immigrantrefugeehealth/guidelines/overseas-guidelines.html //
sickoftalking
an hour ago
The Twitter "trust the experts" crowd need to do their own reading instead of just passing on what other "trust the experts" people say as fact.
https://www.jpost.com/healt...
"Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba, conducted a randomized, controlled, double-blinded trial from May 15, 2020, through the end of January 2021 to evaluate the effectiveness of ivermectin in reducing viral shedding among nonhospitalized patients with mild to moderate COVID-19.
...
Nearly 72% of volunteers treated with ivermectin tested negative for the virus by day six. In contrast, only 50% of those who received the placebo tested negative.
IN ADDITION, the study looked at culture viability, meaning how infectious the patients were, and found that only 13% of ivermectin patients were infectious after six days, compared with 50% of the placebo group – almost four times as many.
“Our study shows first and foremost that ivermectin has antiviral activity,” Schwartz said. “It also shows that there is almost a 100% chance that a person will be noninfectious in four to six days, which could lead to shortening isolation time for these people. This could have a huge economic and social impact.”"
A new pre-print Israeli study has found that people with natural immunity to COVID-19 could be 13 times less likely to contract the respiratory virus than those who were solely vaccinated against the disease.
Conducted by researchers at Maccabi Healthcare and Tel Aviv University, the yet-to-be peer-reviewed study found that when comparing individuals previously infected with the virus and those that received two jabs of the Pfizer-BioNTech shot, those with natural infection saw greater protection against the delta variant and breakthrough infection.
“SARS-CoV-2-naïve vaccinees had a 13.06-fold increased risk for breakthrough infection with the Delta variant compared to those previously infected, when the first event (infection or vaccination) occurred during January and February of 2021,” the study read. “The increased risk was significant for symptomatic disease as well. When allowing the infection to occur at any time before vaccination (from March 2020 to February 2021), evidence of waning natural immunity was demonstrated, though SARS-CoV-2 naïve vaccinees had a 5.96-fold increased risk for breakthrough infection and a 7.13-fold increased risk for symptomatic disease.”
The analysis also found that solely vaccinated individuals “were also at a greater risk for COVID-19-related-hospitalizations compared to those that were previously infected.”
The study ultimately concluded that “natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity” and that “individuals who were both previously infected with SARS-CoV-2 and given a single dose of the vaccine gained additional protection against the Delta variant.”
https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1
Accumulating evidence supports ending isolation and precautions for adults with laboratory-confirmed COVID-19 using a symptom-based strategy. This update incorporates recent evidence to inform the duration of isolation and precautions recommended to prevent transmission of SARS-CoV-2 to others, while limiting unnecessary prolonged isolation and unnecessary use of laboratory testing resources. This interim guidance is based upon information available to date and will be updated as new information becomes available. //
Summary of Key Findings
- Concentrations of SARS-CoV-2 RNA in upper respiratory specimens decline after onset of symptoms. (39,56,61,63,64,66)
- The likelihood of recovering replication-competent virus also declines after onset of symptoms. For patients with mild to moderate COVID-19, replication-competent virus has not been recovered after 10 days following symptom onset. (1,8,31,36,42,61,66) Recovery of replication-competent virus between 10 and 20 days after symptom onset has been reported in some adults with severe COVID-19; some of these cases were immunocompromised. (56) However, in this series of patients, it was estimated that 88% and 95% of their specimens no longer yielded replication-competent virus after 10 and 15 days, respectively, following symptom onset. Detection of sub-genomic SARS-CoV-2 RNA or recovery of replication-competent virus has been reported in severely immunocompromised patients (e.g., patients with chronic lymphocytic leukemia and acquired hypogammaglobulinemia, lymphoma and immunochemotherapy, hematopoietic stem-cell transplant, chimeric antigen receptor T-cell therapy, or AIDS) beyond 20 days, and as long as 143 days after a positive SARS-CoV-2 test result. (2,6,7,14,74)
- In a large contact tracing study, no contacts at high risk of exposure developed infection if their exposure to a case patient started 6 days or more after the case patient’s infection onset. (12)
Recovered patients can continue to have SARS-CoV-2 RNA detected in their upper respiratory specimens for up to 12 weeks after symptom onset. (31,33,34) Investigation of 285 “persistently positive” adults, which included 126 adults who had developed recurrent symptoms, found no secondary infections among 790 contacts to these case patients. Efforts to isolate replication-competent virus from 108 of these 285 case patients were unsuccessful. (31)
January 12, 2021 at 5:45 PM EST
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DOD) will purchase additional supply of the casirivimab and imdevimab antibody cocktail for use in non-hospitalized COVID-19 patients to meet the federal government's Operation Warp Speed goals. The government has said it will provide these doses at no cost to patients, though healthcare facilities may charge fees related to administration.
Under the new agreement, the government will purchase all finished doses of the casirivimab and imdevimab antibody cocktail delivered by June 30, 2021, up to 1.25 million doses. Under a previous agreement, Regeneron is already supplying doses to treat approximately 300,000 people, bringing the total potential purchase to over 1.5 million doses.
Interestingly enough, Abbott and DeSantis may not be in agreement with the CDC, but they are in agreement with a good number of health departments from the rest of the western world. As highlighted by Fox News, many developed countries have come to the same conclusion as Abbott and DeSantis in that it’s unnecessary to mask children, if not irresponsible to do so:
The European Centre for Disease Prevention and Control, an agency of the European Union, does not recommend masks for children 6 and under in any setting or for children 12 and under in a classroom setting. In the Republic of Ireland, children ages 13 and younger are only advised to wear a mask if they attend middle school. In Sweden, children have never been told to wear masks in school.
In Iceland, children ages 15 and younger are exempt from mask requirements. In Norway, schoolchildren 7 and younger are not required to wear masks. When it comes to the U.K., which is reporting a similar COVID-19 surge as the U.S., public health officials in England and Wales are no longer recommending masks in classrooms starting this September. In Scotland, children 12 and under are no longer required to wear face coverings in public places. And officials in Northern Ireland have indicated they plan to drop masking requirements in schools this fall.
In New Zealand, masks are not recommended in schools or for children younger than 6 in any public setting, but children or teachers who wish to wear them “may do so if they want to” and “should not be criticized for doing so,” the country’s Ministry for Education website currently states.
https://www.foxnews.com/politics/desantis-abbott-school-mask-foreign-countries
author David Zweig asserts that the supposed science supporting the imposition of mask mandates isn’t as solid as the left would have us believe. For starters, he brought up a large-scale study conducted by the Centers for Disease Control and Prevention (CDC) which analyzed the spread of COVID-19 in schools.
Zweig writes:
A few major news outlets covered its release by briefly reiterating the study’s summary: that masking then-unvaccinated teachers and improving ventilation with more fresh air were associated with a lower incidence of the virus in schools.
However, the summary left out an important factor:
Distancing, hybrid models, classroom barriers, HEPA filters, and, most notably, requiring student masking were each found to not have a statistically significant benefit. In other words, these measures could not be said to be effective.
The author points to similar results found in European nations such as Ireland, the United Kingdom, France, Italy, and others. Each of these nations has not required children to wear face masks. The article notes that “there’s no evidence of more outbreaks in schools in those countries relative to schools in the U.S.” //
Even more interesting is the fact that the World Health Organization (WHO) has provided guidance regarding mask-wearing that conflicts with the CDC’s recommendations and has found that forcing students to wear masks may actually have a detrimental effect on their development. //
Over the course of several weeks, I also corresponded with many experts — epidemiologists, infectious-disease specialists, an immunologist, pediatricians, and a physician publicly active in matters relating to COVID — asking for the best evidence they were aware of that mask requirements on students were effective. Nobody was able to find a data set as robust as the Georgia results — that is, a large cohort study directly looking at the effects of a mask requirement. //
The notion that the CDC would suppress information demonstrating that their narrative regarding masks for children lacks merit is telling. The reality is clear: The CDC and the left want your kids wearing masks whether they work or not. Why else would they hide this information?
What is already known about this topic?
Early observational studies among nursing home residents showed mRNA vaccines to be 53% to 92% effective against SARS-CoV-2 infection.
What is added by this report?
Two doses of mRNA vaccines were 74.7% effective against infection among nursing home residents early in the vaccination program (March–May 2021). During June–July 2021, when B.1.617.2 (Delta) variant circulation predominated, effectiveness declined significantly to 53.1%.
What are the implications for public health practice?
Multicomponent COVID-19 prevention strategies, including vaccination of nursing home staff members, residents, and visitors, are critical. An additional dose of COVID-19 vaccine might be considered for nursing home and long-term care facility residents to optimize a protective immune response.
Two Canadian doctors recently made the argument that the Pfizer-BioNTech mRNA vaccine is effective enough to warrant a single-dose regimen when communities have a limited supply of the shots. Their letter, published in mid-February when Canada was experiencing a delay in vaccine shipments, states that the vaccine had an efficacy of 92.6% beginning two weeks after the first dose, and before the second was administered. The authors based their analysis on documents Pfizer submitted to the FDA.1 //
Research out of Israel published in The Lancet found that the first dose of the Pfizer COVID-19 vaccine was 85% effective two to three weeks after a single dose.3 Another study found that after one dose of the vaccine, between days 14 to 20, it offered 57% effectiveness for symptomatic COVID-19, 74% for hospitalization, and 62% for severe disease.4
Elander’s Voice
@Elanders_Voice
AUSTRALIA- 24,000 children will be vaccinated in a stadium next week. No parents will be allowed access.
Er… //
The police? Somehow it doesn’t seem any more comforting that a law enforcement agent will be the one “escorting” your child to a forced medical procedure.
Imagine for one second the American military knocking on your door and escorting your children out to receive a treatment you may not feel confident about and they may not want at all.
It blows the mind that such a proud people like the Australians would so willingly submit to outright totalitarianism. To say it is disappointing is an understatement.
It makes one wonder if the current state of the American spirit is prepared to withstand any similar incursions from our own government. //
Liberty Lockdown w/ Clint Russell
@LibertyLockPod
Australia began as a penal colony
And ended as one
Breaking911
@Breaking911
New Zealand is on nationwide lockdown due to 1 single case of COVID-19
“Don’t talk to your neighbors. Please, keep to your bubbles,” Prime Minister Jacinda Ardern tells the public.
Kyle Lamb
@kylamb8
·
Aug 13
In the past day or two, PA, OH, MI, IN, IL & WI all saw huge case increases simultaneously. Did they all suddenly engage in erratic behavior or is there a seasonal pattern causing the spike? Let's go to our CDC correspondent, Mr. Case Curve and take a look.
https://mobile.twitter.com/kylamb8/status/1426191289603792903/photo/1 ///
Seasonal variations
Hawaii, which has had a very restrictive mask-mandate (indoors and outdoors) is getting hit by Delta at exactly the time you’d expect if you were looking at past trends.
The proof? – Hawaii’s largest previous spike happened in August of 2020, the exact month they are seeing a spike this year.
It’s not just Hawaii, though. Many midwestern states are now seeing the same trend play out. //
https://mobile.twitter.com/kylamb8/status/1426191289603792903/photo/1
Mask mandates are not working. The virus has its waves — regardless of whether a state has a mandate in place or not. That means that Florida, which has born the brunt of the criticism, is being largely vindicated. No mask mandate was going to magically fix their situation. If masks were effective, Hawaii, which is literally a group of islands in the middle of the ocean, wouldn’t be seeing their largest spike to date. //.
The correlation between mask mandates and spread does not exist. That may make the fact-checkers on social media uncomfortable, but the data is on my side, and all I can do is share that data. Anyone that doubts that COVID is seasonal and can’t be defeated by mask mandates can check back in three months. We will have seen the same spikes in the same states at around the same time, whether those states have a mask mandate or not.
The virus cannot be “crushed” from that perspective. It can only be managed by vaccinations, natural immunity, and a realization that certain segments of the population are just not statistically vulnerable. Getting the elderly, the obese, and those with other comorbidities vaccinated should be the priority, not making eight-year-olds mask up in school. Common sense needs to prevail.
This should be a lesson to American leftists — and Americans in general — that when you engage in smear campaigns and political messaging without verifying the credibility of the information, it’s not just American voters who are listening. And if your message is finding common ground with Communists seeking to shirk blame for unleashing a plague on the world, perhaps it’s time to rethink your allegiance to the message. As Christina Pushaw, DeSantis’ press secretary, told Dunleavy, “Believing Rebekah Jones’s conspiracy theory means you believe that thousands of public health employees from all 67 counties, many of whom are Democrats, conspired to manipulate COVID numbers to help DeSantis politically. This is outlandish and nonsensical, but countless Americans believe it, and the CCP benefits.”
Charles W. Cooke had the definitive takedown of Ms. Jones in May.
Jones’s central claim is nothing less dramatic than that she has uncovered a massive conspiracy in the third most populous state in the nation, and that, having done so, she has been ruthlessly persecuted by the governor and his “Gestapo.” Specifically, Jones claims that, while she was working at the FDOH last year, she was instructed by her superiors to alter the “raw” data so that Florida’s COVID response would look better, and that, having refused, she was fired. Were this charge true, it would reflect one of the most breathtaking political scandals in all of American history.
But it’s not true. Indeed, it’s nonsense from start to finish. Jones isn’t a martyr; she’s a myth-peddler. She isn’t a scientist; she’s a fabulist. She’s not a whistleblower; she’s a good old-fashioned confidence trickster. And, like any confidence trickster, she understands her marks better than they understand themselves.